AstraZeneca To Initiate Phase-IIb Study For AZD3480

Anonymous User | Login

AstraZeneca To Initiate Phase-IIb Study For AZD3480

Published: 08-Jul-2009

Company also plans to continue development of AZD1446 for Alzheimer’s disease

AstraZeneca is likely to conduct further development of AZD3480, by initiating phase IIb studies in attention deficit/hyperactivity disorder (ADHD). It has agreed to make a $10 million milestone payment to Targacept.

AstraZeneca also plans to continue development of AZD1446 (TC-6683) for Alzheimer’s disease. AZD1446 is currently in phase-I, and was discovered in the ongoing AstraZeneca-Targacept research collaboration.

The company has prioritized the development of AZD1446 over further development of AZD3480. AZD3480 and AZD1446 are selective alpha4beta2 NNR agonists.

AstraZeneca is engaged in the research, development, manufacturing and marketing of prescription medicines. The company is focused on gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines.

GSK's Syncria Improves Glucose Control, Reduces Weight

Syncria (Albiglutide) to reduce blood sugar in the treatment of type2 diabetes. ...

GSK, Chroma Therapeutics Form Alliance

GlaxoSmithKline to invest in Chroma’ Series D equity financing ...

Orexigen Signs Licensing Agreement With GSK

To submit NDA in the first half of 2010 ...

Concert Pharmaceuticals, GlaxoSmithKline Collaborate For Deuterium-containing Medicines

Concert to receive $35 million in upfront payments, and will provide GSK with deuterium-modified versions of three GSK pipeline compounds for development. ...

FDA Approves GlaxoSmithKline' Lamictal XR For Epilepsy Treatment

GlaxoSmithKline has announced that the US Food and Drug Administration (FDA) has approved Lamictal XR (lamotrigine) Extended-Release tablets as once-a-day add-on therapy ...

GlaxoSmithKline Discontinues Development Of Remogliflozin

Discontinuation as a result of evaluating circumstances, including the development status of SGLT2 inhibitors by competitors ...

AstraZeneca's Regulatory Update For Seroquel XR

AstraZeneca has referred its application for Seroquel XR (quetiapine fumarate) extended release tablets, used for the treatment of recurrent depressive episodes in adult ...

US HHS Purchases GSK’s Swine Flu Vaccine And Adjuvant System

GlaxoSmithKline (GSK) has got initial orders from the US Department of Health and Human Services (HHS) for A (H1N1) influenza vaccine antigen and the company’s proprietar ...

Boehringer Ingelheim’ Investigational Combination Witnesses Positive Results

Telmisartan and Amlodipine showed substantial and sustained 24-hour blood pressure lowering ...

WHO Grants Global Prequalification To GSK’s Rotarix Vaccine

Registered in more than 100 countries worldwide and approved by European Medicines Agency and FDA. ...

Network Sites

Contract Research Clinical Trials Contract Services Drug Delivery Drug Discovery & Development OTC Regulatory Affairs Process and Production IT and Software Laboratory Instrumentation Manufacturing Fine & Specialty Chemicals Medical Devices Business Review Inward Investment Packaging

Mail sent successfully

Tell your friend about this article

Please enter a valid email address

Please enter your name

Please enter the mail body

Your Name: *

Your Email: *

Friend's Email: *

Email Body: *: I thought you would be interested in this article : http://www.pharmaceutical-business-review.com/news/astrazeneca_to_initiate_phaseiib_study_for_azd3480_090708/

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Almac

Drug Development Solutions ...

STARLIMS

Benefits for Life Science Labs ...

Parenteral Drug Association (PDA)

Pharmaceutical Information and Education Services ...

Burkert Fluid Control Systems

Fluid and Gas Control Systems ...

IMCOR

LIMS and Laboratory Informatics Consultancy ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Related Companies

AstraZeneca PLC

AstraZeneca PLC (AstraZeneca) is a leading pharmaceuticals company engaged in the desig ...

Boehringer Ingelheim GmbH

Boehringer Ingelheim GmbH (Boehringer) is a group of companies engaged in the research, ...

B. Braun Melsungen AG

B. Braun Melsungen AG (B. Braun) is a global health care company involved in marketing ...

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Teleflex Incorporated

Teleflex Incorporated (Teleflex) is a diversified company engaged in the development, d ...

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750